BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2270348, encodeId=466322e034803, content=偏重的研究方向：microRNA 经验分享：修回后with editor已经2周了。。。会不会被拒啊？？现在到几号投稿了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85a8179531, createdName=ms6000002121995865, createdTime=Sun Jun 22 00:20:42 CST 2025, time=2025-06-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=804128, encodeId=c2f9804128b3, content=审稿速度:1.0 | 投稿命中率:100.0 偏重的研究方向：神经生物学;细胞生物学;分子生物学 经验分享：赶着毕业拿学位，投稿BBRC，非常给力！7月19日晚上提交，立刻分配了稿件号并with editor，7月21日下午稿件退回要求补充上传WB的original images，当天补充完提交，提交后1小时就under review，今天7月23日中午接收，从初次提交到接收用时4天，十分效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=57, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba294682334, createdName=17142086d7m, createdTime=Thu Jul 23 15:29:56 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264200, encodeId=6f932264200dd, content=请问那个short com有啥区别嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f6d6404751, createdName=ms5000000138196922, createdTime=Fri May 09 14:53:58 CST 2025, time=2025-05-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2216361, encodeId=5c692216361e9, content=偏重的研究方向：肿瘤 经验分享：这个杂志现在是真的慢，投稿10天了是一点反馈都没有！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:06:38 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2259388, encodeId=c0432259388fb, content=short communication4.2号投稿，杂志会进行文字和图片查重。第二天就能知道查重结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a12f5512507, createdName=安徽, createdTime=Mon Apr 07 07:13:50 CST 2025, time=2025-04-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172975, encodeId=bbb521e297532, content=偏重的研究方向：分子生物学 经验分享：请问现在送审到多少号啦？我是7434<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=32, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231206/2dee05e08ca84fb09f8330013e8e418e/e2624ef6b4474dc8bf92c7e3eed5d474.jpg, createdBy=4de09089222, createdName=ms5000001058303842, createdTime=Tue Dec 05 09:17:45 CST 2023, time=2023-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2237535, encodeId=db55223e535c0, content=偏重的研究方向：小鼠模型;肿瘤免疫检查点 经验分享：想问问大家，送审多少号了？五个figure，做了三个小鼠模型，基本都是小鼠实验。创新性一般般，这种送审几率大不大呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=anan-prove, createdTime=Mon Nov 18 08:30:50 CST 2024, time=2024-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2247712, encodeId=ee06224e712ba, content=投了20天了，一点动静都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4ac6580068, createdName=ms1000000724685965, createdTime=Sun Jan 12 17:07:38 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248319, encodeId=7f8a224831955, content=投稿快一个月了，还是第一步，到底在干嘛他们，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e099309520, createdName=ms1000001474584470, createdTime=Thu Jan 16 12:12:56 CST 2025, time=2025-01-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2250629, encodeId=81d92250629b2, content=偏重的研究方向：肿瘤;基础 经验分享：当天投当天under review是要被拒了吗？悲观了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47142424112, createdName=girlgo, createdTime=Wed Feb 05 19:05:40 CST 2025, time=2025-02-05, status=1, ipAttribution=)]

2025-06-22 ms6000002121995865 来自北京

偏重的研究方向：microRNA
经验分享：修回后with editor已经2周了。。。会不会被拒啊？？现在到几号投稿了？

10 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2270348, encodeId=466322e034803, content=偏重的研究方向：microRNA 经验分享：修回后with editor已经2周了。。。会不会被拒啊？？现在到几号投稿了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85a8179531, createdName=ms6000002121995865, createdTime=Sun Jun 22 00:20:42 CST 2025, time=2025-06-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=804128, encodeId=c2f9804128b3, content=审稿速度:1.0 | 投稿命中率:100.0 偏重的研究方向：神经生物学;细胞生物学;分子生物学 经验分享：赶着毕业拿学位，投稿BBRC，非常给力！7月19日晚上提交，立刻分配了稿件号并with editor，7月21日下午稿件退回要求补充上传WB的original images，当天补充完提交，提交后1小时就under review，今天7月23日中午接收，从初次提交到接收用时4天，十分效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=57, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba294682334, createdName=17142086d7m, createdTime=Thu Jul 23 15:29:56 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264200, encodeId=6f932264200dd, content=请问那个short com有啥区别嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f6d6404751, createdName=ms5000000138196922, createdTime=Fri May 09 14:53:58 CST 2025, time=2025-05-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2216361, encodeId=5c692216361e9, content=偏重的研究方向：肿瘤 经验分享：这个杂志现在是真的慢，投稿10天了是一点反馈都没有！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:06:38 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2259388, encodeId=c0432259388fb, content=short communication4.2号投稿，杂志会进行文字和图片查重。第二天就能知道查重结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a12f5512507, createdName=安徽, createdTime=Mon Apr 07 07:13:50 CST 2025, time=2025-04-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172975, encodeId=bbb521e297532, content=偏重的研究方向：分子生物学 经验分享：请问现在送审到多少号啦？我是7434<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=32, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231206/2dee05e08ca84fb09f8330013e8e418e/e2624ef6b4474dc8bf92c7e3eed5d474.jpg, createdBy=4de09089222, createdName=ms5000001058303842, createdTime=Tue Dec 05 09:17:45 CST 2023, time=2023-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2237535, encodeId=db55223e535c0, content=偏重的研究方向：小鼠模型;肿瘤免疫检查点 经验分享：想问问大家，送审多少号了？五个figure，做了三个小鼠模型，基本都是小鼠实验。创新性一般般，这种送审几率大不大呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=anan-prove, createdTime=Mon Nov 18 08:30:50 CST 2024, time=2024-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2247712, encodeId=ee06224e712ba, content=投了20天了，一点动静都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4ac6580068, createdName=ms1000000724685965, createdTime=Sun Jan 12 17:07:38 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248319, encodeId=7f8a224831955, content=投稿快一个月了，还是第一步，到底在干嘛他们，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e099309520, createdName=ms1000001474584470, createdTime=Thu Jan 16 12:12:56 CST 2025, time=2025-01-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2250629, encodeId=81d92250629b2, content=偏重的研究方向：肿瘤;基础 经验分享：当天投当天under review是要被拒了吗？悲观了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47142424112, createdName=girlgo, createdTime=Wed Feb 05 19:05:40 CST 2025, time=2025-02-05, status=1, ipAttribution=)]

2020-07-23 17142086d7m

审稿速度:1.0 | 投稿命中率:100.0
偏重的研究方向：神经生物学;细胞生物学;分子生物学
经验分享：赶着毕业拿学位，投稿BBRC，非常给力！7月19日晚上提交，立刻分配了稿件号并with editor，7月21日下午稿件退回要求补充上传WB的original images，当天补充完提交，提交后1小时就under review，今天7月23日中午接收，从初次提交到接收用时4天，十分效率！

406 57 举报

展开57条回复

[GetPortalCommentsPageByObjectIdResponse(id=2270348, encodeId=466322e034803, content=偏重的研究方向：microRNA 经验分享：修回后with editor已经2周了。。。会不会被拒啊？？现在到几号投稿了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85a8179531, createdName=ms6000002121995865, createdTime=Sun Jun 22 00:20:42 CST 2025, time=2025-06-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=804128, encodeId=c2f9804128b3, content=审稿速度:1.0 | 投稿命中率:100.0 偏重的研究方向：神经生物学;细胞生物学;分子生物学 经验分享：赶着毕业拿学位，投稿BBRC，非常给力！7月19日晚上提交，立刻分配了稿件号并with editor，7月21日下午稿件退回要求补充上传WB的original images，当天补充完提交，提交后1小时就under review，今天7月23日中午接收，从初次提交到接收用时4天，十分效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=57, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba294682334, createdName=17142086d7m, createdTime=Thu Jul 23 15:29:56 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264200, encodeId=6f932264200dd, content=请问那个short com有啥区别嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f6d6404751, createdName=ms5000000138196922, createdTime=Fri May 09 14:53:58 CST 2025, time=2025-05-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2216361, encodeId=5c692216361e9, content=偏重的研究方向：肿瘤 经验分享：这个杂志现在是真的慢，投稿10天了是一点反馈都没有！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:06:38 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2259388, encodeId=c0432259388fb, content=short communication4.2号投稿，杂志会进行文字和图片查重。第二天就能知道查重结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a12f5512507, createdName=安徽, createdTime=Mon Apr 07 07:13:50 CST 2025, time=2025-04-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172975, encodeId=bbb521e297532, content=偏重的研究方向：分子生物学 经验分享：请问现在送审到多少号啦？我是7434<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=32, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231206/2dee05e08ca84fb09f8330013e8e418e/e2624ef6b4474dc8bf92c7e3eed5d474.jpg, createdBy=4de09089222, createdName=ms5000001058303842, createdTime=Tue Dec 05 09:17:45 CST 2023, time=2023-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2237535, encodeId=db55223e535c0, content=偏重的研究方向：小鼠模型;肿瘤免疫检查点 经验分享：想问问大家，送审多少号了？五个figure，做了三个小鼠模型，基本都是小鼠实验。创新性一般般，这种送审几率大不大呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=anan-prove, createdTime=Mon Nov 18 08:30:50 CST 2024, time=2024-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2247712, encodeId=ee06224e712ba, content=投了20天了，一点动静都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4ac6580068, createdName=ms1000000724685965, createdTime=Sun Jan 12 17:07:38 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248319, encodeId=7f8a224831955, content=投稿快一个月了，还是第一步，到底在干嘛他们，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e099309520, createdName=ms1000001474584470, createdTime=Thu Jan 16 12:12:56 CST 2025, time=2025-01-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2250629, encodeId=81d92250629b2, content=偏重的研究方向：肿瘤;基础 经验分享：当天投当天under review是要被拒了吗？悲观了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47142424112, createdName=girlgo, createdTime=Wed Feb 05 19:05:40 CST 2025, time=2025-02-05, status=1, ipAttribution=)]

2025-05-09 ms5000000138196922 来自上海

请问那个short com有啥区别嘛？

22 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2270348, encodeId=466322e034803, content=偏重的研究方向：microRNA 经验分享：修回后with editor已经2周了。。。会不会被拒啊？？现在到几号投稿了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85a8179531, createdName=ms6000002121995865, createdTime=Sun Jun 22 00:20:42 CST 2025, time=2025-06-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=804128, encodeId=c2f9804128b3, content=审稿速度:1.0 | 投稿命中率:100.0 偏重的研究方向：神经生物学;细胞生物学;分子生物学 经验分享：赶着毕业拿学位，投稿BBRC，非常给力！7月19日晚上提交，立刻分配了稿件号并with editor，7月21日下午稿件退回要求补充上传WB的original images，当天补充完提交，提交后1小时就under review，今天7月23日中午接收，从初次提交到接收用时4天，十分效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=57, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba294682334, createdName=17142086d7m, createdTime=Thu Jul 23 15:29:56 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264200, encodeId=6f932264200dd, content=请问那个short com有啥区别嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f6d6404751, createdName=ms5000000138196922, createdTime=Fri May 09 14:53:58 CST 2025, time=2025-05-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2216361, encodeId=5c692216361e9, content=偏重的研究方向：肿瘤 经验分享：这个杂志现在是真的慢，投稿10天了是一点反馈都没有！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:06:38 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2259388, encodeId=c0432259388fb, content=short communication4.2号投稿，杂志会进行文字和图片查重。第二天就能知道查重结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a12f5512507, createdName=安徽, createdTime=Mon Apr 07 07:13:50 CST 2025, time=2025-04-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172975, encodeId=bbb521e297532, content=偏重的研究方向：分子生物学 经验分享：请问现在送审到多少号啦？我是7434<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=32, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231206/2dee05e08ca84fb09f8330013e8e418e/e2624ef6b4474dc8bf92c7e3eed5d474.jpg, createdBy=4de09089222, createdName=ms5000001058303842, createdTime=Tue Dec 05 09:17:45 CST 2023, time=2023-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2237535, encodeId=db55223e535c0, content=偏重的研究方向：小鼠模型;肿瘤免疫检查点 经验分享：想问问大家，送审多少号了？五个figure，做了三个小鼠模型，基本都是小鼠实验。创新性一般般，这种送审几率大不大呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=anan-prove, createdTime=Mon Nov 18 08:30:50 CST 2024, time=2024-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2247712, encodeId=ee06224e712ba, content=投了20天了，一点动静都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4ac6580068, createdName=ms1000000724685965, createdTime=Sun Jan 12 17:07:38 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248319, encodeId=7f8a224831955, content=投稿快一个月了，还是第一步，到底在干嘛他们，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e099309520, createdName=ms1000001474584470, createdTime=Thu Jan 16 12:12:56 CST 2025, time=2025-01-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2250629, encodeId=81d92250629b2, content=偏重的研究方向：肿瘤;基础 经验分享：当天投当天under review是要被拒了吗？悲观了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47142424112, createdName=girlgo, createdTime=Wed Feb 05 19:05:40 CST 2025, time=2025-02-05, status=1, ipAttribution=)]

2024-07-22 biocell160 来自贵州省

偏重的研究方向：肿瘤
经验分享：这个杂志现在是真的慢，投稿10天了是一点反馈都没有！

274 9 举报

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2270348, encodeId=466322e034803, content=偏重的研究方向：microRNA 经验分享：修回后with editor已经2周了。。。会不会被拒啊？？现在到几号投稿了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85a8179531, createdName=ms6000002121995865, createdTime=Sun Jun 22 00:20:42 CST 2025, time=2025-06-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=804128, encodeId=c2f9804128b3, content=审稿速度:1.0 | 投稿命中率:100.0 偏重的研究方向：神经生物学;细胞生物学;分子生物学 经验分享：赶着毕业拿学位，投稿BBRC，非常给力！7月19日晚上提交，立刻分配了稿件号并with editor，7月21日下午稿件退回要求补充上传WB的original images，当天补充完提交，提交后1小时就under review，今天7月23日中午接收，从初次提交到接收用时4天，十分效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=57, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba294682334, createdName=17142086d7m, createdTime=Thu Jul 23 15:29:56 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264200, encodeId=6f932264200dd, content=请问那个short com有啥区别嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f6d6404751, createdName=ms5000000138196922, createdTime=Fri May 09 14:53:58 CST 2025, time=2025-05-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2216361, encodeId=5c692216361e9, content=偏重的研究方向：肿瘤 经验分享：这个杂志现在是真的慢，投稿10天了是一点反馈都没有！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:06:38 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2259388, encodeId=c0432259388fb, content=short communication4.2号投稿，杂志会进行文字和图片查重。第二天就能知道查重结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a12f5512507, createdName=安徽, createdTime=Mon Apr 07 07:13:50 CST 2025, time=2025-04-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172975, encodeId=bbb521e297532, content=偏重的研究方向：分子生物学 经验分享：请问现在送审到多少号啦？我是7434<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=32, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231206/2dee05e08ca84fb09f8330013e8e418e/e2624ef6b4474dc8bf92c7e3eed5d474.jpg, createdBy=4de09089222, createdName=ms5000001058303842, createdTime=Tue Dec 05 09:17:45 CST 2023, time=2023-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2237535, encodeId=db55223e535c0, content=偏重的研究方向：小鼠模型;肿瘤免疫检查点 经验分享：想问问大家，送审多少号了？五个figure，做了三个小鼠模型，基本都是小鼠实验。创新性一般般，这种送审几率大不大呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=anan-prove, createdTime=Mon Nov 18 08:30:50 CST 2024, time=2024-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2247712, encodeId=ee06224e712ba, content=投了20天了，一点动静都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4ac6580068, createdName=ms1000000724685965, createdTime=Sun Jan 12 17:07:38 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248319, encodeId=7f8a224831955, content=投稿快一个月了，还是第一步，到底在干嘛他们，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e099309520, createdName=ms1000001474584470, createdTime=Thu Jan 16 12:12:56 CST 2025, time=2025-01-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2250629, encodeId=81d92250629b2, content=偏重的研究方向：肿瘤;基础 经验分享：当天投当天under review是要被拒了吗？悲观了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47142424112, createdName=girlgo, createdTime=Wed Feb 05 19:05:40 CST 2025, time=2025-02-05, status=1, ipAttribution=)]

2025-04-07 安徽来自江苏省

short communication4.2号投稿，杂志会进行文字和图片查重。第二天就能知道查重结果

39 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2270348, encodeId=466322e034803, content=偏重的研究方向：microRNA 经验分享：修回后with editor已经2周了。。。会不会被拒啊？？现在到几号投稿了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85a8179531, createdName=ms6000002121995865, createdTime=Sun Jun 22 00:20:42 CST 2025, time=2025-06-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=804128, encodeId=c2f9804128b3, content=审稿速度:1.0 | 投稿命中率:100.0 偏重的研究方向：神经生物学;细胞生物学;分子生物学 经验分享：赶着毕业拿学位，投稿BBRC，非常给力！7月19日晚上提交，立刻分配了稿件号并with editor，7月21日下午稿件退回要求补充上传WB的original images，当天补充完提交，提交后1小时就under review，今天7月23日中午接收，从初次提交到接收用时4天，十分效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=57, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba294682334, createdName=17142086d7m, createdTime=Thu Jul 23 15:29:56 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264200, encodeId=6f932264200dd, content=请问那个short com有啥区别嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f6d6404751, createdName=ms5000000138196922, createdTime=Fri May 09 14:53:58 CST 2025, time=2025-05-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2216361, encodeId=5c692216361e9, content=偏重的研究方向：肿瘤 经验分享：这个杂志现在是真的慢，投稿10天了是一点反馈都没有！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:06:38 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2259388, encodeId=c0432259388fb, content=short communication4.2号投稿，杂志会进行文字和图片查重。第二天就能知道查重结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a12f5512507, createdName=安徽, createdTime=Mon Apr 07 07:13:50 CST 2025, time=2025-04-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172975, encodeId=bbb521e297532, content=偏重的研究方向：分子生物学 经验分享：请问现在送审到多少号啦？我是7434<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=32, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231206/2dee05e08ca84fb09f8330013e8e418e/e2624ef6b4474dc8bf92c7e3eed5d474.jpg, createdBy=4de09089222, createdName=ms5000001058303842, createdTime=Tue Dec 05 09:17:45 CST 2023, time=2023-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2237535, encodeId=db55223e535c0, content=偏重的研究方向：小鼠模型;肿瘤免疫检查点 经验分享：想问问大家，送审多少号了？五个figure，做了三个小鼠模型，基本都是小鼠实验。创新性一般般，这种送审几率大不大呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=anan-prove, createdTime=Mon Nov 18 08:30:50 CST 2024, time=2024-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2247712, encodeId=ee06224e712ba, content=投了20天了，一点动静都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4ac6580068, createdName=ms1000000724685965, createdTime=Sun Jan 12 17:07:38 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248319, encodeId=7f8a224831955, content=投稿快一个月了，还是第一步，到底在干嘛他们，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e099309520, createdName=ms1000001474584470, createdTime=Thu Jan 16 12:12:56 CST 2025, time=2025-01-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2250629, encodeId=81d92250629b2, content=偏重的研究方向：肿瘤;基础 经验分享：当天投当天under review是要被拒了吗？悲观了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47142424112, createdName=girlgo, createdTime=Wed Feb 05 19:05:40 CST 2025, time=2025-02-05, status=1, ipAttribution=)]

2023-12-05 ms5000001058303842 来自北京

偏重的研究方向：分子生物学
经验分享：请问现在送审到多少号啦？我是7434#期刊论坛#

189 32 举报

展开32条回复

[GetPortalCommentsPageByObjectIdResponse(id=2270348, encodeId=466322e034803, content=偏重的研究方向：microRNA 经验分享：修回后with editor已经2周了。。。会不会被拒啊？？现在到几号投稿了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85a8179531, createdName=ms6000002121995865, createdTime=Sun Jun 22 00:20:42 CST 2025, time=2025-06-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=804128, encodeId=c2f9804128b3, content=审稿速度:1.0 | 投稿命中率:100.0 偏重的研究方向：神经生物学;细胞生物学;分子生物学 经验分享：赶着毕业拿学位，投稿BBRC，非常给力！7月19日晚上提交，立刻分配了稿件号并with editor，7月21日下午稿件退回要求补充上传WB的original images，当天补充完提交，提交后1小时就under review，今天7月23日中午接收，从初次提交到接收用时4天，十分效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=57, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba294682334, createdName=17142086d7m, createdTime=Thu Jul 23 15:29:56 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264200, encodeId=6f932264200dd, content=请问那个short com有啥区别嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f6d6404751, createdName=ms5000000138196922, createdTime=Fri May 09 14:53:58 CST 2025, time=2025-05-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2216361, encodeId=5c692216361e9, content=偏重的研究方向：肿瘤 经验分享：这个杂志现在是真的慢，投稿10天了是一点反馈都没有！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:06:38 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2259388, encodeId=c0432259388fb, content=short communication4.2号投稿，杂志会进行文字和图片查重。第二天就能知道查重结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a12f5512507, createdName=安徽, createdTime=Mon Apr 07 07:13:50 CST 2025, time=2025-04-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172975, encodeId=bbb521e297532, content=偏重的研究方向：分子生物学 经验分享：请问现在送审到多少号啦？我是7434<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=32, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231206/2dee05e08ca84fb09f8330013e8e418e/e2624ef6b4474dc8bf92c7e3eed5d474.jpg, createdBy=4de09089222, createdName=ms5000001058303842, createdTime=Tue Dec 05 09:17:45 CST 2023, time=2023-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2237535, encodeId=db55223e535c0, content=偏重的研究方向：小鼠模型;肿瘤免疫检查点 经验分享：想问问大家，送审多少号了？五个figure，做了三个小鼠模型，基本都是小鼠实验。创新性一般般，这种送审几率大不大呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=anan-prove, createdTime=Mon Nov 18 08:30:50 CST 2024, time=2024-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2247712, encodeId=ee06224e712ba, content=投了20天了，一点动静都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4ac6580068, createdName=ms1000000724685965, createdTime=Sun Jan 12 17:07:38 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248319, encodeId=7f8a224831955, content=投稿快一个月了，还是第一步，到底在干嘛他们，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e099309520, createdName=ms1000001474584470, createdTime=Thu Jan 16 12:12:56 CST 2025, time=2025-01-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2250629, encodeId=81d92250629b2, content=偏重的研究方向：肿瘤;基础 经验分享：当天投当天under review是要被拒了吗？悲观了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47142424112, createdName=girlgo, createdTime=Wed Feb 05 19:05:40 CST 2025, time=2025-02-05, status=1, ipAttribution=)]

2024-11-18 anan-prove 来自山东省

偏重的研究方向：小鼠模型;肿瘤免疫检查点
经验分享：想问问大家，送审多少号了？五个figure，做了三个小鼠模型，基本都是小鼠实验。创新性一般般，这种送审几率大不大呢？

78 21 举报

展开21条回复

[GetPortalCommentsPageByObjectIdResponse(id=2270348, encodeId=466322e034803, content=偏重的研究方向：microRNA 经验分享：修回后with editor已经2周了。。。会不会被拒啊？？现在到几号投稿了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85a8179531, createdName=ms6000002121995865, createdTime=Sun Jun 22 00:20:42 CST 2025, time=2025-06-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=804128, encodeId=c2f9804128b3, content=审稿速度:1.0 | 投稿命中率:100.0 偏重的研究方向：神经生物学;细胞生物学;分子生物学 经验分享：赶着毕业拿学位，投稿BBRC，非常给力！7月19日晚上提交，立刻分配了稿件号并with editor，7月21日下午稿件退回要求补充上传WB的original images，当天补充完提交，提交后1小时就under review，今天7月23日中午接收，从初次提交到接收用时4天，十分效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=57, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba294682334, createdName=17142086d7m, createdTime=Thu Jul 23 15:29:56 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264200, encodeId=6f932264200dd, content=请问那个short com有啥区别嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f6d6404751, createdName=ms5000000138196922, createdTime=Fri May 09 14:53:58 CST 2025, time=2025-05-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2216361, encodeId=5c692216361e9, content=偏重的研究方向：肿瘤 经验分享：这个杂志现在是真的慢，投稿10天了是一点反馈都没有！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:06:38 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2259388, encodeId=c0432259388fb, content=short communication4.2号投稿，杂志会进行文字和图片查重。第二天就能知道查重结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a12f5512507, createdName=安徽, createdTime=Mon Apr 07 07:13:50 CST 2025, time=2025-04-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172975, encodeId=bbb521e297532, content=偏重的研究方向：分子生物学 经验分享：请问现在送审到多少号啦？我是7434<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=32, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231206/2dee05e08ca84fb09f8330013e8e418e/e2624ef6b4474dc8bf92c7e3eed5d474.jpg, createdBy=4de09089222, createdName=ms5000001058303842, createdTime=Tue Dec 05 09:17:45 CST 2023, time=2023-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2237535, encodeId=db55223e535c0, content=偏重的研究方向：小鼠模型;肿瘤免疫检查点 经验分享：想问问大家，送审多少号了？五个figure，做了三个小鼠模型，基本都是小鼠实验。创新性一般般，这种送审几率大不大呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=anan-prove, createdTime=Mon Nov 18 08:30:50 CST 2024, time=2024-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2247712, encodeId=ee06224e712ba, content=投了20天了，一点动静都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4ac6580068, createdName=ms1000000724685965, createdTime=Sun Jan 12 17:07:38 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248319, encodeId=7f8a224831955, content=投稿快一个月了，还是第一步，到底在干嘛他们，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e099309520, createdName=ms1000001474584470, createdTime=Thu Jan 16 12:12:56 CST 2025, time=2025-01-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2250629, encodeId=81d92250629b2, content=偏重的研究方向：肿瘤;基础 经验分享：当天投当天under review是要被拒了吗？悲观了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47142424112, createdName=girlgo, createdTime=Wed Feb 05 19:05:40 CST 2025, time=2025-02-05, status=1, ipAttribution=)]

2025-01-12 ms1000000724685965 来自上海

投了20天了，一点动静都没有。

54 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2270348, encodeId=466322e034803, content=偏重的研究方向：microRNA 经验分享：修回后with editor已经2周了。。。会不会被拒啊？？现在到几号投稿了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85a8179531, createdName=ms6000002121995865, createdTime=Sun Jun 22 00:20:42 CST 2025, time=2025-06-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=804128, encodeId=c2f9804128b3, content=审稿速度:1.0 | 投稿命中率:100.0 偏重的研究方向：神经生物学;细胞生物学;分子生物学 经验分享：赶着毕业拿学位，投稿BBRC，非常给力！7月19日晚上提交，立刻分配了稿件号并with editor，7月21日下午稿件退回要求补充上传WB的original images，当天补充完提交，提交后1小时就under review，今天7月23日中午接收，从初次提交到接收用时4天，十分效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=57, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba294682334, createdName=17142086d7m, createdTime=Thu Jul 23 15:29:56 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264200, encodeId=6f932264200dd, content=请问那个short com有啥区别嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f6d6404751, createdName=ms5000000138196922, createdTime=Fri May 09 14:53:58 CST 2025, time=2025-05-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2216361, encodeId=5c692216361e9, content=偏重的研究方向：肿瘤 经验分享：这个杂志现在是真的慢，投稿10天了是一点反馈都没有！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:06:38 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2259388, encodeId=c0432259388fb, content=short communication4.2号投稿，杂志会进行文字和图片查重。第二天就能知道查重结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a12f5512507, createdName=安徽, createdTime=Mon Apr 07 07:13:50 CST 2025, time=2025-04-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172975, encodeId=bbb521e297532, content=偏重的研究方向：分子生物学 经验分享：请问现在送审到多少号啦？我是7434<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=32, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231206/2dee05e08ca84fb09f8330013e8e418e/e2624ef6b4474dc8bf92c7e3eed5d474.jpg, createdBy=4de09089222, createdName=ms5000001058303842, createdTime=Tue Dec 05 09:17:45 CST 2023, time=2023-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2237535, encodeId=db55223e535c0, content=偏重的研究方向：小鼠模型;肿瘤免疫检查点 经验分享：想问问大家，送审多少号了？五个figure，做了三个小鼠模型，基本都是小鼠实验。创新性一般般，这种送审几率大不大呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=anan-prove, createdTime=Mon Nov 18 08:30:50 CST 2024, time=2024-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2247712, encodeId=ee06224e712ba, content=投了20天了，一点动静都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4ac6580068, createdName=ms1000000724685965, createdTime=Sun Jan 12 17:07:38 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248319, encodeId=7f8a224831955, content=投稿快一个月了，还是第一步，到底在干嘛他们，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e099309520, createdName=ms1000001474584470, createdTime=Thu Jan 16 12:12:56 CST 2025, time=2025-01-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2250629, encodeId=81d92250629b2, content=偏重的研究方向：肿瘤;基础 经验分享：当天投当天under review是要被拒了吗？悲观了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47142424112, createdName=girlgo, createdTime=Wed Feb 05 19:05:40 CST 2025, time=2025-02-05, status=1, ipAttribution=)]

2025-01-16 ms1000001474584470 来自北京

投稿快一个月了，还是第一步，到底在干嘛他们，急死了

40 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2270348, encodeId=466322e034803, content=偏重的研究方向：microRNA 经验分享：修回后with editor已经2周了。。。会不会被拒啊？？现在到几号投稿了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85a8179531, createdName=ms6000002121995865, createdTime=Sun Jun 22 00:20:42 CST 2025, time=2025-06-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=804128, encodeId=c2f9804128b3, content=审稿速度:1.0 | 投稿命中率:100.0 偏重的研究方向：神经生物学;细胞生物学;分子生物学 经验分享：赶着毕业拿学位，投稿BBRC，非常给力！7月19日晚上提交，立刻分配了稿件号并with editor，7月21日下午稿件退回要求补充上传WB的original images，当天补充完提交，提交后1小时就under review，今天7月23日中午接收，从初次提交到接收用时4天，十分效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=57, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba294682334, createdName=17142086d7m, createdTime=Thu Jul 23 15:29:56 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264200, encodeId=6f932264200dd, content=请问那个short com有啥区别嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f6d6404751, createdName=ms5000000138196922, createdTime=Fri May 09 14:53:58 CST 2025, time=2025-05-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2216361, encodeId=5c692216361e9, content=偏重的研究方向：肿瘤 经验分享：这个杂志现在是真的慢，投稿10天了是一点反馈都没有！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:06:38 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2259388, encodeId=c0432259388fb, content=short communication4.2号投稿，杂志会进行文字和图片查重。第二天就能知道查重结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a12f5512507, createdName=安徽, createdTime=Mon Apr 07 07:13:50 CST 2025, time=2025-04-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2172975, encodeId=bbb521e297532, content=偏重的研究方向：分子生物学 经验分享：请问现在送审到多少号啦？我是7434<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=32, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231206/2dee05e08ca84fb09f8330013e8e418e/e2624ef6b4474dc8bf92c7e3eed5d474.jpg, createdBy=4de09089222, createdName=ms5000001058303842, createdTime=Tue Dec 05 09:17:45 CST 2023, time=2023-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2237535, encodeId=db55223e535c0, content=偏重的研究方向：小鼠模型;肿瘤免疫检查点 经验分享：想问问大家，送审多少号了？五个figure，做了三个小鼠模型，基本都是小鼠实验。创新性一般般，这种送审几率大不大呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=anan-prove, createdTime=Mon Nov 18 08:30:50 CST 2024, time=2024-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2247712, encodeId=ee06224e712ba, content=投了20天了，一点动静都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4ac6580068, createdName=ms1000000724685965, createdTime=Sun Jan 12 17:07:38 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248319, encodeId=7f8a224831955, content=投稿快一个月了，还是第一步，到底在干嘛他们，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e099309520, createdName=ms1000001474584470, createdTime=Thu Jan 16 12:12:56 CST 2025, time=2025-01-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2250629, encodeId=81d92250629b2, content=偏重的研究方向：肿瘤;基础 经验分享：当天投当天under review是要被拒了吗？悲观了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47142424112, createdName=girlgo, createdTime=Wed Feb 05 19:05:40 CST 2025, time=2025-02-05, status=1, ipAttribution=)]

2025-02-05 girlgo

偏重的研究方向：肿瘤;基础
经验分享：当天投当天under review是要被拒了吗？悲观了

47 2 举报

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务